Worth reading
30Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Resolved 24 August 2026Incoming appointee
2 itemsScheduled Appointment Date1 September 2026
Nanbu Shohei (南部 翔平)
Previous positionDirector of Alpaca Family Clinic; Representative Director of SeaTurtle Co., Ltd. (currently serving)
New positionMandate-based executive officer (AI business)
Nakamura Hiromitsu (中村 宏光)
Previous positionPhysician at Zetith Beauty Clinic Ginza (currently serving)
New positionMandate-based executive officer (AI business)
Reason for change
To strengthen the development structure
| Item | Details |
|---|---|
| Resolution date | 24 August 2026 |
| Scheduled Appointment Date | 1 September 2026 |
| Name of appointee | Nanbu Shohei (南部 翔平), Nakamura Hiromitsu (中村 宏光) |
| Appointee's new position | Mandate-based executive officer (AI business), Mandate-based executive officer (AI business) |
| Appointee's previous position | Director of Alpaca Family Clinic; Representative Director of SeaTurtle Co., Ltd. (currently serving), Physician at Zetith Beauty Clinic Ginza (currently serving) |
| Reason for change | To strengthen the development structure |
Items this document does not state (15)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The two individuals, who had been involved as external collaborators in the planning and development of AXON, an AI agent system for medical institutions, were appointed mandate-based executive officers to strengthen the development structure.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.